Clinical Trial Update: A 14-week Pilot Prospective Clinical Trial With BiOkuris Product in Patients With Irritable Bowel Syndrome [NA]

View source ↗

Summary

A 14-week pilot prospective clinical trial tested BiOkuris Product in patients with Irritable Bowel Syndrome. The study has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Irritable Bowel Syndrome

Drugs mentioned

• BiOkuris Product

Snippet

Sponsor: Biokuris s.a. | Conditions: Irritable Bowel Syndrome | NA | Status: COMPLETED